$VYGR 8-K SEC Filings

Filed On	Filing
21 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This Amended and Restated Employment Agreement (this “Agreement”) is made as of October 20, 2026 (the “Effective Date”) by and between Voyager Therapeutics, Inc. (the “Company”) and Robin Swartz (the “Executive”).
06 Aug 2026	8-K: Results of Operations and Financial Condition
13 Jul 2026	8-K: Other Events
10 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
01 Jun 2026	8-K: Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
21 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
09 Mar 2026	8-K: Results of Operations and Financial Condition
12 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
08 Jan 2026	8-K: Regulation FD Disclosure
10 Nov 2025	8-K: Results of Operations and Financial Condition
02 Sep 2025	8-K: Regulation FD Disclosure
06 Aug 2025	8-K: Results of Operations and Financial Condition
05 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
06 May 2025	8-K: Results of Operations and Financial Condition
11 Mar 2025	8-K: Results of Operations and Financial Condition
11 Feb 2025	8-K: Other Events
12 Nov 2024	8-K: Results of Operations and Financial Condition
05 Sep 2024	8-K: Entry into a Material Definitive Agreement
06 Aug 2024	8-K: Results of Operations and Financial Condition

Comments